ArticleCureus2026
Clinician Education and Workflow Tools to Improve Access to Recurrent and Metastatic Cervical Cancer Treatment.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatients with recurrent or metastatic cervical cancer often face delays in treatment due to complex prior authorization (PA) processes and uneven access to specialty care. Educational interventions targeting clinicians and care teams may help streamline workflows and improve access to timely, evidence-based treatment.
objectiveTo describe the design, implementation, and outcomes of a multidisciplinary quality-improvement initiative aimed at improving provider knowledge, administrative efficiency, and access to cervical cancer care.
methodsThe King County Medical Society (KCMS) launched the Cervical Cancer Education and Equity Initiative. The project combined clinician education with practical workflow tools, including a freely available Prior Authorization Toolkit. Activities included 21 short educational videos, a comprehensive slide-based educational module, monthly newsletters, social-media dissemination, and a centralized web hub integrating resources on immunotherapy, targeted therapy, and biomarker-driven care. Eighty-three clinicians completed the baseline survey (N=83), and 30 clinicians completed the follow-up survey, 30/83 (36.1%). Post-intervention surveys assessed clinician knowledge, confidence, and perceived impact on practice.
resultsAcross knowledge/confidence items, 26/30 (86.7%) respondents completed each rating question; mean post-program scores ranged from 3.7 to 4.0 out of 5.0. For post-intervention practice change items, respondents reported earlier referral to specialists, 11/25 (44.0%); more frequent discussion of clinical trial options, 6/25 (24.0%); and increased attention to transportation, financial, or social-support barriers when planning care, 10/25 (40.0%). Respondents reported considering social determinants of health more often after the program, 17/25 (68.0%); 4/25 (16.0%) reported no change, and 4/25 (16.0%) indicated the item was not applicable to their role. A total of 1,869 views were recorded across 21 on-demand educational videos during the program period. All educational materials remained publicly accessible.
conclusionsTargeted, workflow-aligned education paired with practical administrative tools may reduce barriers to cervical cancer treatment. This initiative demonstrates a replicable model for improving access to advanced oncology care through clinician education and systems-focused interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.